IMGN Financial Facts
Research and development: 32.91MResearch and development support: 1.35M
See Full Income Statement
Total liabilities: 353.89M
Commitments and contingencies (Note E): 0
See Full Balance Sheet
Immunogen Inc. (IMGN) Earnings
|
Expand Research on IMGN
Next EPS Date | 4/25/24 *Est. | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | +73.5% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | +51.9% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
11/2/23 | Q323 | $0.10 | $0.04 | +$0.06 | $113.4M | $103.68M | N/A | Details | |||
2/12/21 | Q420 | $0.16 | -$0.10 | +$0.26 | $85.8M | $37.09M | = | Details | |||
7/31/23 | Q223 | -$0.02 | -$0.13 | +$0.11 | $77.4M | $49.15M | N/A | Details | |||
4/28/23 | Q123 | -$0.16 | -$0.25 | +$0.09 | $49.9M | $20.97M | N/A | Details | |||
1/30/15 | Q215 | $0.16 | -$0.05 | +$0.21 | $48.3M | $37.3M | N/A | Details | |||
2/14/20 | Q419 | $0.03 | -$0.05 | +$0.08 | $44.9M | $29.33M | = | Details | |||
3/1/23 | Q422 | -$0.23 | -$0.30 | +$0.07 | $41.17M | $17.43M | N/A | Details | |||
2/9/18 | Q417 | -$0.11 | -$0.12 | +$0.01 | $39.45M | $32.71M | = | Details |